SA
NBIX logo
Neurocrine Biosciences, Inc.(NBIX)
Closing price · checked 8:45 PM ETAbout this dataData status
$162.78▼-3.06 (-1.84%)
Pre-Market:$162.00-0.78 (-0.48%)· 8:45 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average (VIX 22.3)

Overview →

Neurocrine Biosciences, Inc. (NBIX)

Operating Expenses

$2.74B

TTM · Period ending: · USD

NBIX logo

NBIX Operating Expenses

Latest reported$2.74B
NBIX Operating Expenses ($17.30M → $2.74B)
High-resolution chart · PNG

What is operating expenses?

Expenses from normal business operations (SG&A, R&D, etc.).

NBIX operating expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Neurocrine Biosciences, Inc. Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
2,189,300,000
1,750,800,000
1,596,500,000
1,216,500,000
1,016,700,000
872,800,000
708,400,000
409,500,000
291,733,000
162,372,000
113,971,000
64,411,000
52,597,000
51,692,000
43,491,000
47,223,000
56,623,000
91,273,000
213,466,000
152,551,000
148,961,000
137,510,000
197,865,000
121,660,000
85,124,000
52,387,000
38,800,000
30,100,000
26,900,000
17,300,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.